T40.992 Poisoning by other psychodysleptics [hallucinogens], intentional self-harm

Name of the Condition

• Poisoning by other psychodysleptics [hallucinogens], intentional self-harm

Summary

This ICD code describes intentional self-harm resulting from poisoning by other psychodysleptics (hallucinogens). It applies to cases where deliberate exposure to these substances causes toxic effects, typically due to self-inflicted ingestion or administration. Psychodysleptics alter perception, mood, or consciousness, and their intentional use in self-harm can lead to acute physiological or psychological symptoms.

Causes

Intentional self-harm may occur from deliberate ingestion of hallucinogens, such as mescaline, DMT, or other substances not classified elsewhere. It can result from suicidal intent, self-experimentation, or attempts to induce altered states for self-harm purposes. Interactions with other substances may exacerbate toxicity.

Risk Factors

• History of suicidal ideation or attempts.
• Concurrent mental health conditions (e.g., depression, psychosis).
• Access to hallucinogens.
• Prior substance use or misuse.
• Lack of social support or supervision.

Symptoms

• Altered perception, including visual or auditory hallucinations.
• Anxiety, paranoia, or panic.
• Disorientation or confusion.
• Increased heart rate or blood pressure.
• Nausea, vomiting, or dizziness.
• Potential for severe psychological distress or self-injurious behavior.

Diagnosis

Diagnosis involves clinical evaluation of symptoms, patient history, and toxicology screening to confirm exposure to hallucinogens. Healthcare providers assess the intent of self-harm, often through direct patient communication or collateral information. Physical exams and lab tests may identify physiological effects, while mental health assessments address underlying psychological factors.

Treatment Options

Treatment focuses on stabilizing the patient, managing acute symptoms, and addressing the self-harm intent. This may include supportive care, monitoring vital signs, and administering medications to counteract toxicity. Psychological interventions, such as crisis counseling or psychiatric evaluation, are critical for long-term management.

Prognosis and Follow-Up

Prognosis depends on the severity of poisoning, timely intervention, and underlying mental health status. Follow-up care often involves ongoing psychiatric support, therapy, and monitoring for recurrence of self-harm behaviors. Early intervention improves outcomes, particularly when addressing co-occurring conditions.

Complications

Complications may include prolonged psychological effects (e.g., persistent hallucinations), organ damage from toxicity, or worsening mental health. Severe cases can lead to respiratory depression, cardiovascular issues, or fatal outcomes if untreated.

Lifestyle & Prevention

Prevention strategies include restricting access to hallucinogens, promoting mental health awareness, and providing resources for individuals at risk of self-harm. Education on the dangers of intentional substance use and early intervention for mental health concerns are key.

When to Seek Professional Help

Seek immediate medical attention if self-harm with hallucinogens is suspected, especially with symptoms like severe disorientation, physiological distress, or suicidal intent. Prompt care reduces risks of complications and supports psychological recovery.

Tips for Medical Coders

Use this code for cases of intentional self-harm via hallucinogen poisoning. Document intent clearly, as it differentiates from accidental or undetermined poisoning. Ensure clinical notes support the self-harm context, including patient statements or observed behaviors, to justify code assignment.